[1] Bobdey S, Sathwara J, Jain A,et al. Burden of cervical cancer and role of screening in India[J].Indian J Med Paediatr Oncol,2016, 37(4):278-285. [2] Gonzálezquintana V, Palmaberré L, Camposparra AD, et al. MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).[J].Oncol Rep,2015, 35(1):3. [3] Zhao H, Liu S, Wang G, et al. Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer[J].Oncol Rep,2014, 33(2):591-598. [4] Gl I, Erkin O. Knowledge and practices of nurses on cervical cancer, HPV and HPV vaccine in Cankiri state hospital, Turkey[J].J Pak Med Assoc,2016,66(12):1621-1626. [5] Hasahya OT, Berggren V, Sematimba D, et al. Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign[J].Glob Health Action,2016, 9:293-336.
2017, Vol. 34 
